Gold standard monitoring of HCC in patients with cirrhosis is cost-effective
Hepatocellular carcinoma (HCC) is the leading cause of death in patients with cirrhosis. A new analysis indicates that following screening guidelines for HCC in cirrhotic patients is lifesaving and cost-effective compared ...
Feb 8, 2017
0
0